Reinventing biomanufacturing
Univercells Technologies delivers novel biomanufacturing platforms as a direct answer to the growing demand for viral vaccines and viral vectors. We leverage integration and continuous processing principles to significantly reduce the overall manufacturing footprint and deliver cost-effective and scalable manufacturing of high-quality therapies.
A unique fixed-bed technology for intensified processes
The scale-X™ bioreactor delivers intensified production of adherent and suspension cells as well as viral products. Its unique proprietary structured fixed-bed design consist of spiral-wound alternating sheets of non-woven PET fabric and spacer netting.
Scalability in the scale-X bioreactor range relies on the principle of constant linear velocity of fluids with surface area increase. This ensures that the residence time remains constant at any scale.
Have a look inside the scale-X™ fixed-bed bioreactor
Discover how its unique structured fixed-bed is designed to provide a healthy environment for your adherent and suspension cells, helping them deliver more.
The principles of integration and continuous processing
Our novel fixed-bed bioreactors are integrated within automated and continuous platforms. This enables a reduction in operational volume, manual operations and overall costs while delivering increased throughput per cleanroom surface.
Integration of unit steps into a single continuous and automated platform offers an alternative to stand-alone unit operations and equipment. The drastic footprint and cost reductions have been demonstrated through the NevoLine™ sIPV proof-of-concept. The scale-X™ carbo system and the NevoLine™ Upstream platform feature an in-line TFF concentration step delivering a continuously concentrated harvest for simplified purification.
Scalability from discovery to commercial manufacturing
The scale-X fixed-bed bioreactors are at the core of our biomanufacturing platforms.
Our portfolio covers applications from small-scale R&D to large-scale GMP commercial manufacturing.
The scale-X hydro system was developed to support early development activities.
The mid-scale scale-X carbo system bridges the gap from development to clinical production. The NevoLine Upstream platform, featuring the large-scale scale-X nitro bioreactor, provides a solution for cost-effective large capacity production.
Discover our products
scale-X™ hydro system
Small-scale production for early-stage process development
scale-X™ carbo system
Low-footprint, intermediate-scale process development and GMP production
scale-X™ cell collect
Seed train made simple
NevoLine™ Upstream platform
Integrated and automated commercial upstream manufacturing